Global and India Biological Defense Measures Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Software
Publisher : MRA | Format : PDF
Global and India Biological Defense Measures Market Report & Forecast 2024-2034
Biological Defense Measure is a set of medical or military measures. These are taken in response to the demand for restoring the biosecurity of a country against biological toxins or infectious agents. The agents can be used with the intent to kill or infect humans, animals, or the environment and to instigate biological warfare. Biological agents used during bioterrorism are usually living organisms. These can include bacteria, viruses, fungi, or toxins that are deliberately used to sicken and kill creating social and economic turmoil.
Market Analysis and InsightsGlobal and India Biological Defense Measures Market
This report focuses on global and India Biological Defense Measures market, also covers the segmentation data of other regions in regional level and county level.
The global Biological Defense Measures revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India the Biological Defense Measures revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Biological Defense Measures include Alnylam Pharmaceuticals Inc, Aeolus Pharmaceuticals, Achaogen, Arbutus Biopharma, Altimmune Inc, Bavarian Nordic, Cleveland Biolabs, Emergent Biosolutions Inc and Elusys Therapeutics Inc, etc. The global five biggest players hold a share of % in 2023.
Global Biological Defense Measures Scope and Market Size
Biological Defense Measures market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Biological Defense Measures market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Biological Defense Measures market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
Alnylam Pharmaceuticals Inc
Aeolus Pharmaceuticals
Achaogen
Arbutus Biopharma
Altimmune Inc
Bavarian Nordic
Cleveland Biolabs
Emergent Biosolutions Inc
Elusys Therapeutics Inc
Dynport Vaccine Company
Dynavax Technologies Corporation
Hytest
Ichor Medical Systems
GSK
SIGA Technologies
Sanofi
Soligenix
Ology Bioservices
PharmAthene
Xoma Corporation
Segment by Type
Biological
Chemical
Radiological
Nuclear (CBRN) Warfare Agents
Others
Medical
Military
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Biological Defense Measures definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Biological Defense Measures companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Biological Defense Measures in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biological Defense Measures revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and India Biological Defense Measures Market
This report focuses on global and India Biological Defense Measures market, also covers the segmentation data of other regions in regional level and county level.
The global Biological Defense Measures revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India the Biological Defense Measures revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Biological Defense Measures include Alnylam Pharmaceuticals Inc, Aeolus Pharmaceuticals, Achaogen, Arbutus Biopharma, Altimmune Inc, Bavarian Nordic, Cleveland Biolabs, Emergent Biosolutions Inc and Elusys Therapeutics Inc, etc. The global five biggest players hold a share of % in 2023.
Global Biological Defense Measures Scope and Market Size
Biological Defense Measures market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Biological Defense Measures market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Biological Defense Measures market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.
By Company
Alnylam Pharmaceuticals Inc
Aeolus Pharmaceuticals
Achaogen
Arbutus Biopharma
Altimmune Inc
Bavarian Nordic
Cleveland Biolabs
Emergent Biosolutions Inc
Elusys Therapeutics Inc
Dynport Vaccine Company
Dynavax Technologies Corporation
Hytest
Ichor Medical Systems
GSK
SIGA Technologies
Sanofi
Soligenix
Ology Bioservices
PharmAthene
Xoma Corporation
Segment by Type
Biological
Chemical
Radiological
Nuclear (CBRN) Warfare Agents
Others
Segment by Application
Medical
Military
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Biological Defense Measures definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Biological Defense Measures companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Biological Defense Measures in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biological Defense Measures revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices